Atlas Trials

Study to Learn More About the Effect of a New Drug Called BAY2327949 on the Blood Flow Through Kidneys in Adult Participants With Moderate Chronic Kidney Disease

Clinical trial NCT04552262 · TERMINATED

Trial details

NCT number
NCT04552262
Sponsor
Bayer
Status
TERMINATED
Phase
Phase 1
Study type
INTERVENTIONAL
Moderate Chronic Kidney Disease
Start date
2020-09-30
Primary completion
2020-12-21
Enrollment
7

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.